Pharmacovigilance Market share to exceed $8bn by 2024: Global Market Insights Inc. The global industry report "Pharmacovigilance Market Size By Clinical Trial Phase (Preclinical, Phase I, Phase II, Phase III, Phase IV), By Service Provider (Inhouse, Contract outsourcing) Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, Spain, Italy, France, China, Japan, India, Australia, Argentina, Brazil, Mexico, South Africa, Saudi Arabia, UAE, Qatar), Application Potential, Price Trends, Competitive Market Share & Forecast, 2016 – 2024" by Global Market Insights, Inc. says Worldwide Pharmacovigilance Market having had a revenue of USD 3 billion in 2015, is predicted to surpass a revenue collection of USD 8 billion by 2024. The crucial need to monitor the efficiency and aftereffects of drugs will drive pharmacovigilance market. The field of pharmacovigilance globally represents the picture of drug effectiveness, safety, and associated risk detection. It is expected that even life science manufacturers will become more proactive due to adoption of pharmacovigilance services, which will stimulate the industry trends. Implementation of stringent rules and regulations regarding clinical trial management and drugs safety will also influence pharmacovigilance industry size.
Most of the pharmaceutical and biotechnology firms are adopting these services to maintain and manage clinical trial data, which will favorably influence pharmacovigilance market share from in-house companies, which generated a revenue of USD 1.5 billion in 2015 and is likely to increase two-fold by 2024. Companies established in the developed countries often outsource these services, considering the operational cost reduction effectiveness and quality. The notable business participants in pharmacovigilance market are Accenture, Boehringer Ingelheim, Covance, PAREXEL, Bristol-Myers Squibb, Quintiles, Cognizant Technology Solutions Corporation, United BioSource, and ICON. Contract outsourcing covered more than 50% of the revenue share of the service provider segment in pharmacovigilance industry in 2015 and will exceed a revenue collection of USD 4.8 billion by 2024. The growing adoption of this segment by the various pharmaceutical firms will stimulate the product demand noticeably.
1|Page
U.S. Pharmacovigilance Market size, by service provider, 20122024 (USD Million)
Browse key industry insights spread across 111 pages with 66 market data tables & 6 figures & charts from this 2017 report Pharmacovigilance Market in detail along with the table of contents at: https://www.gminsights.com/industry-analysis/pharmacovigilance-market Asia Pacific pharmacovigilance market having had a revenue of USD 835 million in 2015, will surpass a revenue collection of USD 2.4 billion by 2024. The attributing factors toward the market growth are stringent regulations regarding health, rise in number of clinical trials, and a massive patient base. The region will witness a surge in the number of pre-clinical trials, subject to which pharmacovigilance market from pre-clinical trials will generate a revenue of more than USD 84 million by 2024 with an annual growth rate of 10.3% over the years ahead. U.S. pharmacovigilance industry collected a revenue of USD 1 billion in 2015 and will exceed a revenue generation of USD 2.5 billion by 2024 with an annual growth rate of 10.7% over the period of 2016 to 2024. Surging need to monitor the significant effects of medical drugs owing to the increasing mortality rate subject to adverse drug effects will stimulate the product demand. Moreover, rising concern among patients regarding the effectiveness and safety of drugs is predicted to boost pharmacovigilance market size. The need to evaluate drug efficiency based on risk benefit ratio will fuel pharmacovigilance market from phase III clinical trials, which will collect a revenue of more than USD 1,254 million by 2024, having been valued over USD 492 million in 2015. Europe pharmacovigilance market will collect a revenue of USD 1.8 billion by 2024 with a CAGR of 9.9% over the coming seven years. The growth can be attributed to the escalating requirement of personalized medicines. Germany, Spain, and UK covered more than 70% of the Europe regional revenue share in 2015. 2|Page
Industry giants are engaged in strategic partnerships with research organizations to enhance the effectiveness of the product. Mergers & acquisitions is a major growth strategy adopted by the market players to comply with competitiveness of the business.
Table of Content of Pharmacovigilance Market:
Chapter 1. Methodology and Scope 1.1. Research Methodology 1.1.1. Initial data exploration 1.1.2. Statistical modeling and forecast 1.1.3. Industry insights and validation 1.1.4. Research scope and assumptions 1.2. Data Sources 1.2.1. Primary Sources 1.2.2. Secondary Sources Chapter 2. Executive Summary 2.1. Pharmacovigilance industry 3600 synopsis, 2012 - 2024 2.1.1. Business trends 2.1.2. End user trends 2.1.3. Regional trends Chapter 3. Pharmacovigilance Industry Insights 3.1. Industry segmentation 3.2. Industry size and forecast, 2012 - 2024 3.3. Industry impact forces 3.3.1. Growth drivers
3|Page
3.3.1.1.
Increase in adoption rate of outsourcing services
3.3.1.2.
Increasing consumption of drugs
3.3.1.3.
Rise in adverse drug reactions (ADR) and drug toxicity
3.3.2. Industry pitfalls & challenges 3.3.2.1.
Dearth of availability of skilled personnel
3.3.2.2.
High risk associated with data security
3.4. Growth potential analysis 3.4.1. New business models 3.5. Porter’s analysis 3.6. Regulatory Landscape 3.7. Pharmacovigilance Reporting system 3.8. Company market share analysis, 2015 3.8.1. Strategy dashboard 3.9. PESTEL analysis
About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
4|Page
Contact Us:
Arun Hegde Corporate Sales, USA Global Market Insights, Inc. Phone: 1-302-846-7766 Toll Free: 1-888-689-0688 Email: sales@gminsights.com Website: https://www.gminsights.com/ Connect with us: Google+ | LinkedIn | Facebook | Twitter
5|Page